Literature DB >> 20678762

[Mortality prognosis factors in heart failure in a cohort of North-West Spain. EPICOUR study].

J López Castro1, R Almazán Ortega, M Pérez De Juan Romero, J R González Juanatey.   

Abstract

AIMS: Heart failure (HF) is a serious health problem in Spain because it has a high mortality rate and causes considerable costs to the health-care system. This paper presents a study made in the Spanish province of Ourense to study the survival of patients with HF related to the ventricular function or other possible risk factors (RF) associated with the HF prognosis.
MATERIAL AND METHODS: A prospective cohort study was performed, considering any patient hospitalized due to HF from 1 January 1999 to 31 December 2002 (5318 patients) who had undergone an echocardiography that showed systolic or diastolic dysfunction as potential participants (2387 patients). After at least 24 months of the index episode of hospitalization, a sample of 2384 patients was chosen by random sampling. The principal measurement was based on survival and the differences observed in the performance of the left ventricular ejection fraction, of functional class (FC) of HF and of other clinical and epidemiological characteristics. The Kaplan-Meier, log-rank and Cox tests were used.
RESULTS: Mean age of the patients 74.84 (range 36-95); 53.4% males and 56.5% first admission. The most common antecedent was arterial hypertension (HTA) (59.9%), followed by valvulopathy (41.9%) and heart disease (HD) (26.8%). A total of 44.3% of the patients had atrial fibrillation-flutter (AF). Global survival at 5 years was 47.9% and specific survival rate for HF was 74.8%. There were no significant differences in survival between patients with heart failure and preserved systolic function (HF-PSF) and those who suffered systolic dysfunction (p=0.248). Prognostic factors of mortality in patients with HF are: advanced functional class (class III-IV) prior to admission (Hazard ratio [HR] 5.37), deterioration of the glomerular filtration rate (GFR) (HR 0.98), hypoalbuminemia (HR 0.59), hyponatremia (HR 0.93) and hyperkalemia (HR 1.79). The Castelli index higher than 4.5 is in the limit of statistical significance.
CONCLUSIONS: Global survival rate observed at 5 years of research is similar to the results found in already-published papers. Specific survival rate for HF is lower and there are no differences in the survival rate with regard to the left ventricle ejection fraction (E(f)). However, we show that hypoalbuminemia, hyperkalemia and high Castelli index are important prognostic factors of mortality in patients with HF.
Copyright © 2009 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20678762     DOI: 10.1016/j.rce.2010.02.009

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  4 in total

1.  The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failure.

Authors:  Tetsuya Takahashi; Tetsu Watanabe; Tetsuro Shishido; Ken Watanabe; Takayuki Sugai; Taku Toshima; Daisuke Kinoshita; Miyuki Yokoyama; Harutoshi Tamura; Satoshi Nishiyama; Takanori Arimoto; Hiroki Takahashi; Tamon Yamanaka; Takuya Miyamoto; Isao Kubota
Journal:  Heart Vessels       Date:  2017-12-29       Impact factor: 2.037

2.  Serum Albumin Is a Marker of Myocardial Fibrosis, Adverse Pulsatile Aortic Hemodynamics, and Prognosis in Heart Failure With Preserved Ejection Fraction.

Authors:  Stuart B Prenner; Raj Pillutla; Sowjanya Yenigalla; Sowmya Gaddam; Jonathan Lee; Mary Jo Obeid; Armghan Haider Ans; Qasim Jehangir; Jessica Kim; Payman Zamani; Jeremy A Mazurek; Scott R Akers; Julio A Chirinos
Journal:  J Am Heart Assoc       Date:  2020-02-03       Impact factor: 5.501

3.  B-Type Natriuretic Peptide at Admission Is a Predictor of All-Cause Mortality at One Year after the First Acute Episode of New-Onset Heart Failure with Preserved Ejection Fraction.

Authors:  Liviu-Nicolae Ghilencea; Gabriel-Cristian Bejan; Marilena-Brîndusa Zamfirescu; Ana Maria Alexandra Stănescu; Lavinia-Lucia Matei; Laura-Maria Manea; Ismail Dogu Kilic; Serban-Mihai Bălănescu; Andreea-Catarina Popescu; Saul Gareth Myerson
Journal:  J Pers Med       Date:  2022-05-28

4.  [Survival of patients with heart failure in primary care].

Authors:  Antonio Sarría-Santamera; Francisco Javier Prado-Galbarro; María Auxiliadora Martín-Martínez; Rocío Carmona; Ana Estela Gamiño Arroyo; Carlos Sánchez-Piedra; Sofía Garrido Elustondo; Isabel del Cura González
Journal:  Aten Primaria       Date:  2014-12-06       Impact factor: 1.137

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.